To earn trust, every day.
Adobe Flash Player version 9 (or greater) is required to view this banner. Click here to install the latest version of Flash.
Human Prescription - Cardiovascular Disease - Central Nervous System - Anesthesia - Immunology and Infectious Diseases - Oncology - Respiratory - Women's Health
Animal Health
Consumer Health Care
January 9, 2009Schering-Plough to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
January 6, 2009Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings
December 31, 2008Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa
December 19, 2008Schering-Plough Provides Update on Dividend Payment Date for Mandatory Convertible Preferred Stock
December 12, 2008Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
December 10, 2008Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:
